Type 2 Diabetes
Conditions
Brief summary
A long-term low carbohydrate, high monounsaturated fat diet, compared to a high carbohydrate, low glycemic index diet, results in more rapid progression of diabetes; i.e. increased fasting glucose and glycated hemoglobin, reduced beta-cell function and insulin sensitivity and increased free fatty acids. The deleterious effects of a high carbohydrate diet on plasma lipids are only temporary and do not persist beyond 6 months. A long-term high carbohydrate, low glycemic index diet, compared to a high carbohydrate, high glycemic index diet, improves glycemic control and beta-cell function
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* male or non-pregnant/non-lactating females with type 2 diabetes treated by diet alone * age 53-75y * body mass index 25-40kg/m\^2 (Caucasian) or 23-40kg/m\^2 (other) * HbA1c \<=130% of upper limit of normal of local hospital lab
Exclusion criteria
* use of any hypoglycemic or anti-hyperglycemic drug within 6 months of randomization * major cardiovascular event or major surgery within 6 months of randomization * serum triglycerides \>10mmol/L * presence of other major debilitating disorder such as liver disease, renal failure or cancer * presence of gastrointestinal disorder or use of drug which is likely to alter gastrointestinal motility or nutrient absorption * use of oral steroids * substance or alcohol abuse * simultaneous participation in another clinical trial * allergy or intolerance to more than one of wheat, barley, corn, oats, potato, legumes, nuts, psyllium, olives, avocado or canola * unwilling or unable to follow the protocol and/or give informed consent * subjects planning to be on holiday for more than 8 weeks in a row or a total of 12 weeks in the year in locations to which they will not take study food
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| glycated hemoglobin | — |
Secondary
| Measure | Time frame |
|---|---|
| waist circumference | — |
| occurrence of diet failure | — |
| fasting glucose | — |
| fasting C-reactive protein | — |
| fasting lipids (total, HDL and LDL cholesterol and triglcyerides) | — |
| fasting apolipoproteins A1 and B100 | — |
| fasting free fatty acids | — |
| Body weight | — |
| plasma glucose and insulin 30, 60 and 120min after 75g oral glucose | — |
| insulin sensitivity (HOMA) | — |
| beta-cell function (30min-fasting insulin)/(30min-fasting glucose) | — |
| metabolic profile (glucose, insulin, triglycerides and FFA during 8h profile) | — |
| quality of life | — |
| gastrointestinal symptoms | — |
| diet satisfactio | — |
| fasting short chain fatty acids | — |
Countries
Canada